Skip to main content

Table 2 Average daily anticholinergic burden score identified according to each four scales in the study population (N = 461,034)

From: Comparative associations between anticholinergic burden and emergency department visits for anticholinergic adverse events in older Korean adults: a nested case-control study using national claims data for validation of a novel country-specific scale

Scale Any exposure Score 0 Score 1 Score 2 Score ≥ 3
N (%) N (%) N (%) N (%) N (%)
KABS 249,523 (54.1) 324,457 (70.4) 86,278 (18.7) 27,436 (6.0) 22,863 (5.0)
ARS 173,533 (37.6) 394,441 (85.6) 54,499 (11.8) 9143 (2.0) 2951 (0.6)
ACB 267,386 (58.0) 295,633 (64.1) 112,597 (24.4) 30,704 (6.7) 22,100 (4.8)
ADS 252,078 (54.7) 322,466 (69.9) 90,167 (19.6) 30,784 (6.7) 17,617 (3.8)
  1. AB anticholinergic burden, KABS Korean Anticholinergic Burden Scale, ARS Anticholinergic Risk Scale, ACB Anticholinergic Cognitive Burden scale, ADS Anticholinergic Drug Scale
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us